Conditions: Type 2 Diabetes
Keywords: Type 2 diabetes metformin
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 822
Healthy volunteers: no

Brief summary:
Saxagliptin is a new investigational medication being developed for treatment of type 2 diabetes. This study is designed to assess the efficacy and tolerability of saxagliptin in addition to metformin and compare to sitagliptin in addition with metformin.

Detailed description:

Arms:
arm 1: saxagliptin add-on to metformin arm 2: sitagliptin add-on to metformin

Interventions: intervention 1: saxagliptin intervention 2: sitagliptin
Intervention descriptions: intervention 1: tablet, per oral, once daily intervention 2: capsule, per oral, once daily

Protocol document: